INVA
Innoviva Inc

1,568
Mkt Cap
$2.08B
Volume
380,831.00
52W High
$22.76
52W Low
$16.52
PE Ratio
14.18
INVA Fundamentals
Price
$19.77
Prev Close
$19.51
Open
$19.57
50D MA
$19.93
Beta
0.32
Avg. Volume
933,052.37
EPS (Annual)
$0.3621
P/B
1.46
Rev/Employee
$2.93M
Loading...
Loading...
News
all
press releases
Innoviva (NASDAQ:INVA) Share Price Crosses Above Two Hundred Day Moving Average - Here's Why
Innoviva (NASDAQ:INVA) Stock Crosses Above Two Hundred Day Moving Average - Here's Why...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Innoviva, Inc. (NASDAQ:INVA - Get Free Report) have been given an average rating of "Moderate Buy" by the seven research firms that are presently covering the company, Marketbeat Ratings...
MarketBeat·11d ago
News Placeholder
FDA Approves Innoviva's NUZOLVENCE, First-in-Class Oral Treatment For Gonorrhea
(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a...
Nasdaq News: Markets·12d ago
News Placeholder
U.S. FDA Approves NUZOLVENCE (zoliflodacin), a First-in-Class, Single-dose, Oral Antibiotic for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Adolescents
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral...
Business Wire·12d ago
News Placeholder
Innoviva Specialty Therapeutics Announces Publication in The Lancet of Positive Zoliflodacin Phase 3 Data for the Treatment of Uncomplicated Urogenital Gonorrhea
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced the publication of positive results from a pivotal Phase 3 trial evaluating its investigational...
Business Wire·13d ago
News Placeholder
State Board of Administration of Florida Retirement System Cuts Stake in Innoviva, Inc. $INVA
State Board of Administration of Florida Retirement System decreased its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 80.4% in the second quarter, according to its most recent 13F filing...
MarketBeat·17d ago
News Placeholder
Innoviva, Inc. $INVA Shares Purchased by Arrowstreet Capital Limited Partnership
Arrowstreet Capital Limited Partnership raised its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 85.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·19d ago
News Placeholder
Boston Partners Boosts Holdings in Innoviva, Inc. $INVA
Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 40.6% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 875,084...
MarketBeat·25d ago
News Placeholder
Innoviva, Inc. $INVA Shares Purchased by American Century Companies Inc.
American Century Companies Inc. raised its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 23.3% in the 2nd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·25d ago
News Placeholder
Jefferies Financial Group Inc. Increases Stake in Innoviva, Inc. $INVA
Jefferies Financial Group Inc. raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 421.0% during the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·27d ago
<
1
2
...
>

Latest INVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.